全文获取类型
收费全文 | 19632篇 |
免费 | 1475篇 |
国内免费 | 387篇 |
专业分类
耳鼻咽喉 | 105篇 |
儿科学 | 377篇 |
妇产科学 | 290篇 |
基础医学 | 2541篇 |
口腔科学 | 275篇 |
临床医学 | 2605篇 |
内科学 | 4091篇 |
皮肤病学 | 357篇 |
神经病学 | 960篇 |
特种医学 | 418篇 |
外国民族医学 | 1篇 |
外科学 | 1737篇 |
综合类 | 1392篇 |
现状与发展 | 2篇 |
一般理论 | 47篇 |
预防医学 | 2991篇 |
眼科学 | 273篇 |
药学 | 1344篇 |
18篇 | |
中国医学 | 532篇 |
肿瘤学 | 1138篇 |
出版年
2024年 | 23篇 |
2023年 | 2101篇 |
2022年 | 2827篇 |
2021年 | 6007篇 |
2020年 | 4470篇 |
2019年 | 257篇 |
2018年 | 240篇 |
2017年 | 193篇 |
2016年 | 223篇 |
2015年 | 241篇 |
2014年 | 392篇 |
2013年 | 411篇 |
2012年 | 312篇 |
2011年 | 390篇 |
2010年 | 342篇 |
2009年 | 323篇 |
2008年 | 305篇 |
2007年 | 319篇 |
2006年 | 307篇 |
2005年 | 241篇 |
2004年 | 253篇 |
2003年 | 221篇 |
2002年 | 145篇 |
2001年 | 129篇 |
2000年 | 105篇 |
1999年 | 82篇 |
1998年 | 68篇 |
1997年 | 54篇 |
1996年 | 61篇 |
1995年 | 43篇 |
1994年 | 29篇 |
1993年 | 39篇 |
1992年 | 27篇 |
1991年 | 29篇 |
1990年 | 22篇 |
1989年 | 13篇 |
1988年 | 11篇 |
1987年 | 8篇 |
1985年 | 36篇 |
1984年 | 37篇 |
1983年 | 23篇 |
1982年 | 23篇 |
1981年 | 23篇 |
1980年 | 16篇 |
1979年 | 13篇 |
1977年 | 10篇 |
1976年 | 5篇 |
1975年 | 10篇 |
1974年 | 6篇 |
1973年 | 18篇 |
排序方式: 共有10000条查询结果,搜索用时 78 毫秒
991.
992.
Escarlata Angullo-Martínez Enrique Carretero-Anibarro Ignacio Manuel Snchez Barrancos Xavier Cos Claramunt Domingo Orozco Beltrn Jos Luis Torres Baile Patxi Ezkurra Loiola en representacin del Grupo de Trabajo de Diabetes de la SemFyC en representacin del Grupo de Trabajo de Diabetes de la SemFyC 《Atencion primaria / Sociedad Espa?ola de Medicina de Familia y Comunitaria》2021,53(4)
Las circunstancias actuales provocadas por la COVID-19 nos obligan a los profesionales de atención primaria a idear nuevas formas de garantizar la atención sanitaria de nuestros pacientes con diabetes tipo 2 (DM2). Existen evidencias que respaldan la eficacia de la telemedicina en el control glucémico de los pacientes con DM2. Ante la rápida adaptación de la práctica clínica al uso de la telemedicina, el Grupo de Trabajo de Diabetes de la Sociedad Española de Medicina Familiar y Comunitaria (SemFyC) optó por elaborar un documento de consenso plasmado en un algoritmo de actuación/seguimiento telemático en la atención de los pacientes con DM2.Palabras clave: Telemedicina, Diabetes mellitus tipo 2, COVID-19 相似文献
993.
《Vaccine》2021,39(17):2434-2444
BackgroundAchieving universal immunization coverage and reaching every child with life-saving vaccines will require the implementation of pro-equity immunization strategies, especially in poorer countries. Gavi-supported countries continue to implement and report strategies that aim to address implementation challenges and improve equity. This paper summarizes the first mapping of these strategies from country reports.MethodsThirteen Gavi-supported countries were purposively selected with emphasis on Gavi’s priority countries. Following a scoping of different documents submitted to Gavi by countries, 47 Gavi Joint Appraisals (JAs) for the period 2016–2019 from the 13 selected countries were included in the mapping. We used a consolidated framework synthesized from 16 different equity and health systems frameworks, which incorporated UNICEF’s coverage and equity assessment approach – an adaptation of the Tanahashi model. Using search terms, the mapping was conducted using a combination of manual search and the MAXQDA qualitative analysis tool. Pro-equity strategies meeting the inclusion criteria were identified and compiled in an Excel database, and then populated on a tableau visualization dashboard.ResultsIn total, 258 pro-equity strategies were implemented by the 13 sampled Gavi-supported countries between 2016 and 2019. The framework determinants of social norms, utilization, and management and coordination accounted for more than three-quarters of all pro-equity strategies implemented in these countries. The median number of strategies reported per country was 17. Afghanistan, Nigeria, and Uganda reported the highest number of strategies that we considered as pro-equity.ConclusionFindings from this mapping can be useful in addressing equity gaps, reaching partially immunized, and ‘zero-dose’ vaccinated children, and valuable resource for countries planning to implement pro-equity strategies, especially as immunization stakeholders reimagine immunization delivery in light of COVID-19, and as Gavi finalizes its fifth organizational strategy. Future efforts should seek to identify pro-equity strategies being implemented across additional countries, and to assess the extent to which these strategies have improved immunization coverage and equity. 相似文献
994.
Eloy Maldonado-Marcos Cèlia Caula-Freixa Pere Planellas-Giné José Ignacio Rodríguez-Hermosa Santiago López-Ben Olga Delisau-Puig Antoni Codina Cazador 《Cirugía espa?ola》2021,99(5):368-373
IntroductionSARS-CoV-2 pandemic has caused an important impact in our country and elective surgery has been postponed in most cases. There's not known information about the decreasing and impact on surgery. Mortality of surgical patients with SARS-CoV-2 infection is estimated to be around 20%.MethodsWe conducted prospective data recruitment of people inpatient in our Digestive and General Surgery section of Girona's University Hospital Dr. Josep Trueta from 03/14 to 05/11. Our objective is to analyze the impact that SARS-CoV-2 pandemic over elective and urgent surgery.ResultsDuring the peak occupation of our center Intensive Care Unit (303.8%) there was a reduction on elective (93.8%) and urgent (72.7%) surgery. Mortality of patients with SARS-CoV-2 infection who underwent surgery (n = 10) is estimated to be a 10%. An 80% of these patients suffer complications (sever complications in 30%).ConclusionsThe actual study shows a global reduction of the surgical activity (elective and urgent) during de SARS-CoV-2 pandemic. Global mortality of patients with SARS-CoV-2 infection are low, but the severe complications have been over the usual. 相似文献
995.
996.
Clinical outcomes of initially asymptomatic patients with COVID-19: a Korean nationwide cohort study
Hayne Cho Park Do Hyoung Kim Ajin Cho Juhee Kim Kyu-sang Yun Jinseog Kim Young-Ki Lee 《Annals of medicine》2021,53(1):357
BackgroundThis study was performed to compare severe clinical outcome between initially asymptomatic and symptomatic infections and to identify risk factors associated with high patient mortality among initially asymptomatic patients.MethodsIn this retrospective, nationwide cohort study, we included 5621 patients who had been discharged from isolation or died from COVID-19 by 30 April 2020. The mortality rate and admission rate to intensive care unit (ICU) were compared between initially asymptomatic and symptomatic patients. We established a prediction model for patient mortality through risk factor analysis among initially asymptomatic patients.ResultsThe prevalence of initially asymptomatic patients upon admission was 25.8%. The mortality rates were not different between groups (3.3% vs. 4.5%, p = .17). However, initially symptomatic patients were more likely to receive ICU care compared to initially asymptomatic patients (4.1% vs. 1.0%, p < .0001). The age-adjusted Charlson comorbidity index score (CCIS) was the most potent predictor for patient mortality in initially asymptomatic patients.Conclusions The mortality risk was not determined by the initial presence of symptom among hospitalized COVID-19 patients. The CCIS was the most potent predictors for mortality. The clinicians should predict the risk of death by evaluating age and comorbidities but not the initial presence of symptom.
Key messages
- The mortality rate was not different between initially asymptomatic and symptomatic patients.
- Symptomatic patients were more likely to admitted to the intensive care unit.
- Age and comorbidities were the potent risk factors for mortality.
997.
Inayat Ali 《Annals of medicine》2021,53(1):581
Although coronavirus disease 2019 (COVID-19) is a pandemic, it has several specificities influencing its outcomes due to the entwinement of several factors, which anthropologists have called "syndemics". Drawing upon Singer and Clair’s syndemics model, I focus on synergistic interaction among chronic kidney disease (CKD), diabetes, and COVID-19 in Pakistan. I argue that over 36 million people in Pakistan are standing at a higher risk of contracting COVID-19, developing severe complications, and losing their lives. These two diseases, but several other socio-cultural, economic, and political factors contributing to structured vulnerabilities, would function as confounders. To deal with the critical effects of these syndemics the government needs appropriate policies and their implementation during the pandemic and post-pandemic. To eliminate or at least minimize various vulnerabilities, Pakistan needs drastic changes, especially to overcome (formal) illiteracy, unemployment, poverty, gender difference, and rural and urban difference. 相似文献
998.
999.
There is considerable concern in the mental health community about the psychological consequences of the coronavirus pandemic and who may be most vulnerable. Obsessive-compulsive disorder (OCD) symptoms may be particularly sensitive to the context of the pandemic. Previous research suggests insomnia symptoms may contribute to increased OCD symptoms over time, particularly during times of stress, such as the pandemic. The present study examined pre-coronavirus outbreak insomnia symptoms as a predictor of post-coronavirus outbreak OCD symptoms in a sample of community adults who completed a 2016 survey study and were re-contacted on April 1, 2020 (N = 369). Results revealed a small significant increase in OCD symptoms following the coronavirus outbreak and a small significant decrease in insomnia symptoms. Pre-coronavirus outbreak insomnia symptoms significantly predicted increases in post-coronavirus outbreak OCD symptoms. Similar results were found for specific OCD symptom facets with the exception of washing and hoarding symptoms, which were unrelated to pre-coronavirus insomnia symptoms. There was no evidence for a reverse effect of prior OCD symptoms on insomnia symptoms during the pandemic. These findings suggest those with insomnia symptoms prior to the coronavirus pandemic may be vulnerable to increases in some OCD symptoms during the pandemic. The implications for preventing adverse psychological responses during the coronavirus pandemic are discussed. 相似文献
1000.
目的:探讨血清鳞状细胞癌抗原(SCC-Ag)、细胞角蛋白19片段抗原(CYFRA21-1)及血管内皮生长因子(VEGF)水平与宫颈癌临床病理特征及预后的关系。方法:选取2010年1月至2012年12月海南西部中心医院收治的146例宫颈癌患者、50例宫颈上皮内瘤病变(CIN)患者(CIN组)和50例正常健康女性(对照组),比较各组血清SCC-Ag、CYFRA21-1及VEGF水平。分析宫颈癌患者血清SCC-Ag、CYFRA21-1及VEGF水平与临床病理特征的关系,采用Kaplan-Meier法分析不同临床病理特征患者生存率差异,多因素COX比例风险回归模型分析宫颈癌患者预后的影响因素。结果:宫颈癌组血清SCC-Ag、CYFRA21-1及VEGF水平均明显高于CIN组和对照组[SCCA(ng/ml):9.04±2.35 vs 1.91±0.62和0.65±0.14;CYFRA21-1(ng/ml):5.48±1.62 vs 0.92±0.43和0.64±0.25;VEGF(pg/ml):326.42±48.15 vs 125.48±23.60和108.62±18.73,均P<0.01]。血清SCC-Ag、CYFRA21-1及VEGF水平与宫颈癌患者的临床分期、病理分级、淋巴结转移、浸润深度及脉管浸润相关(P<0.05)。单因素及多因素COX回归分析显示,临床分期[HR(95%CI):2.016(1.512~2.915)]、淋巴结转移[HR(95%CI):4.013(2.937~6.016)]、SCC-Ag[HR(95%CI):2.972(2.106~4.618)]、CYFRA21-1[HR(95%CI):1.704(1.335~2.519)]及VEGF[HR(95%CI):2.116(1.685~3.164)]阳性表达是宫颈癌患者预后不良的危险因素。结论:宫颈癌患者血清SCC-Ag、CYFRA21-1及VEGF水平明显升高,SCC-Ag、CYFRA21-1及VEGF阳性表达是影响宫颈癌患者预后不良的危险因素。 相似文献